Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report

Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapse...

Full description

Saved in:
Bibliographic Details
Published inAnnals of hematology Vol. 103; no. 5; pp. 1775 - 1777
Main Authors Wang, Jiawen, Zhu, Han, Miao, Kourong
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2024
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapsed acute myeloid leukemia (R/R AML) patient. In this case, the patient received a combination treatment of Gilteritinib, Venetoclax, and Azacitidine. Remarkably, this treatment not only reduced myeloblasts but also facilitated the restoration of erythroid hematopoiesis.
AbstractList Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapsed acute myeloid leukemia (R/R AML) patient. In this case, the patient received a combination treatment of Gilteritinib, Venetoclax, and Azacitidine. Remarkably, this treatment not only reduced myeloblasts but also facilitated the restoration of erythroid hematopoiesis.
Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapsed acute myeloid leukemia (R/R AML) patient. In this case, the patient received a combination treatment of Gilteritinib, Venetoclax, and Azacitidine. Remarkably, this treatment not only reduced myeloblasts but also facilitated the restoration of erythroid hematopoiesis.Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapsed acute myeloid leukemia (R/R AML) patient. In this case, the patient received a combination treatment of Gilteritinib, Venetoclax, and Azacitidine. Remarkably, this treatment not only reduced myeloblasts but also facilitated the restoration of erythroid hematopoiesis.
Author Wang, Jiawen
Miao, Kourong
Zhu, Han
Author_xml – sequence: 1
  givenname: Jiawen
  surname: Wang
  fullname: Wang, Jiawen
  organization: The first affiliated hospital of Nanjing Medical University, Jiangsu Province Hospital
– sequence: 2
  givenname: Han
  surname: Zhu
  fullname: Zhu, Han
  organization: The first affiliated hospital of Nanjing Medical University, Jiangsu Province Hospital
– sequence: 3
  givenname: Kourong
  surname: Miao
  fullname: Miao, Kourong
  email: kourongmiao@163.com
  organization: The first affiliated hospital of Nanjing Medical University, Jiangsu Province Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38556531$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1TAQhS1URG8LL8ACWWLDJtQ_cZywQxUUpErd0HU0Scati2MH2wEuD8hz4dsUkFjgjTWa75wz0jkhRz54JOQ5Z685Y_osMSa0rpioK6Y0r6v9I7LjtRRlbOsjsmOd7CpV3jE5SemOMS7aWjwhx7JVqlGS78jPC-syRputtwMdwzxYjxP9ZvMt_YoecxgdfKfgJwo_YCzcVABqQqQRHSypwDCuGem8RxfsRB2un3G2UMzGNUb0eXNb1ohFM9ERnaOwOEgFAlPSKTgXbkqaHektzpDDEizmMqWM8ybIEXwqIp8h2-Df0BIA6eC4hJifkscGXMJnD_8puX7_7tP5h-ry6uLj-dvLapSiyZVmwgiNfADTdsw0MEoDWphBcGVaPhnGWgM4NRK6QXfdwPUkOt0oVk-q7gZ5Sl5tvksMX1ZMuZ9tOtwHHsOaeslE1_JGqa6gL_9B78IafbmuUFI3jVTiQImNGmNIKaLpl2hniPues_7Qcr-13JeW-_uW-30RvXiwXocZpz-S37UWQG5AKit_g_Fv9n9sfwEmW7p0
Cites_doi 10.1038/s41409-020-01124-6
10.1111/j.1365-2141.2008.07216.x
10.1111/bjh.17463
10.1159/000337022
10.1182/blood-2003-05-1738
10.1056/NEJMoa1807438
10.1111/ejh.13343
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
7X8
DOI 10.1007/s00277-024-05714-y
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-0584
EndPage 1777
ExternalDocumentID 10_1007_s00277_024_05714_y
38556531
Genre Journal Article
Case Reports
GrantInformation_xml – fundername: Miao Kourong
  grantid: 81470329; 81470329; 81470329
– fundername: Miao Kourong
  grantid: 81470329
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
-~X
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
23M
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AACDK
AAEOY
AAFGU
AAHNG
AAIAL
AAJBT
AAJKR
AAKSU
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBMV
ACBRV
ACBXY
ACBYP
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACTTH
ACUDM
ACVWB
ACWMK
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFQL
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFBBN
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
YLTOR
Z45
Z7U
Z82
Z83
Z87
Z8O
Z8V
Z8W
Z91
ZMTXR
ZOVNA
ZXP
~EX
~KM
AJOOF
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
CITATION
K9.
7X8
ID FETCH-LOGICAL-c326t-702f27e1baf890f6ac3fa72fb215f81df008faed63a9b799b17d2976504d549b3
IEDL.DBID U2A
ISSN 0939-5555
1432-0584
IngestDate Sat Aug 17 04:47:21 EDT 2024
Fri Sep 13 09:33:21 EDT 2024
Thu Sep 12 19:40:30 EDT 2024
Wed Oct 09 10:32:07 EDT 2024
Sat Apr 13 05:06:42 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Refractory/relapsed acute myeloid leukemia
Allogeneic hematopoietic stem cell transplantation
Pure red cell aplasia
Language English
License 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c326t-702f27e1baf890f6ac3fa72fb215f81df008faed63a9b799b17d2976504d549b3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
PMID 38556531
PQID 3037663529
PQPubID 54039
PageCount 3
ParticipantIDs proquest_miscellaneous_3029816559
proquest_journals_3037663529
crossref_primary_10_1007_s00277_024_05714_y
pubmed_primary_38556531
springer_journals_10_1007_s00277_024_05714_y
PublicationCentury 2000
PublicationDate 2024-05-01
PublicationDateYYYYMMDD 2024-05-01
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Berlin
PublicationTitle Annals of hematology
PublicationTitleAbbrev Ann Hematol
PublicationTitleAlternate Ann Hematol
PublicationYear 2024
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Sawada, Fujishima, Hirokawa (CR1) 2008; 142
Chapuy (CR6) 2018; 379
Longval (CR2) 2021; 193
Roychowdhury, Linker (CR7) 1995; 16
Marco-Ayala (CR5) 2021; 56
Jung (CR3) 2012; 5
Salas, Alahmari, Lipton (CR4) 2020; 104
Saunthararajah (CR8) 2003; 102
Y Saunthararajah (5714_CR8) 2003; 102
CI Chapuy (5714_CR6) 2018; 379
T Longval (5714_CR2) 2021; 193
DF Roychowdhury (5714_CR7) 1995; 16
K Sawada (5714_CR1) 2008; 142
MQ Salas (5714_CR4) 2020; 104
SH Jung (5714_CR3) 2012; 5
J Marco-Ayala (5714_CR5) 2021; 56
References_xml – volume: 16
  start-page: 471
  issue: 3
  year: 1995
  end-page: 472
  ident: CR7
  article-title: Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin
  publication-title: Bone Marrow Transpl
  contributor:
    fullname: Linker
– volume: 56
  start-page: 769
  issue: 4
  year: 2021
  end-page: 778
  ident: CR5
  article-title: Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question
  publication-title: Bone Marrow Transpl
  doi: 10.1038/s41409-020-01124-6
  contributor:
    fullname: Marco-Ayala
– volume: 142
  start-page: 505
  issue: 4
  year: 2008
  end-page: 514
  ident: CR1
  article-title: Acquired pure red cell aplasia: updated review of treatment
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2008.07216.x
  contributor:
    fullname: Hirokawa
– volume: 193
  start-page: 814
  issue: 4
  year: 2021
  end-page: 826
  ident: CR2
  article-title: Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study
  publication-title: Br J Haematol
  doi: 10.1111/bjh.17463
  contributor:
    fullname: Longval
– volume: 5
  start-page: 110
  issue: 1
  year: 2012
  end-page: 113
  ident: CR3
  article-title: Successful treatment of pure red cell aplasia with Rituximab in patients after ABO-Compatible allogeneic hematopoietic stem cell transplantation
  publication-title: Case Rep Oncol
  doi: 10.1159/000337022
  contributor:
    fullname: Jung
– volume: 102
  start-page: 3865
  issue: 12
  year: 2003
  end-page: 3870
  ident: CR8
  article-title: Effects of 5-aza-2’-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease
  publication-title: Blood
  doi: 10.1182/blood-2003-05-1738
  contributor:
    fullname: Saunthararajah
– volume: 379
  start-page: 1846
  issue: 19
  year: 2018
  end-page: 1850
  ident: CR6
  article-title: Daratumumab for delayed red-cell engraftment after allogeneic transplantation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1807438
  contributor:
    fullname: Chapuy
– volume: 104
  start-page: 145
  issue: 2
  year: 2020
  end-page: 147
  ident: CR4
  article-title: Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab
  publication-title: Eur J Haematol
  doi: 10.1111/ejh.13343
  contributor:
    fullname: Lipton
– volume: 56
  start-page: 769
  issue: 4
  year: 2021
  ident: 5714_CR5
  publication-title: Bone Marrow Transpl
  doi: 10.1038/s41409-020-01124-6
  contributor:
    fullname: J Marco-Ayala
– volume: 142
  start-page: 505
  issue: 4
  year: 2008
  ident: 5714_CR1
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2008.07216.x
  contributor:
    fullname: K Sawada
– volume: 104
  start-page: 145
  issue: 2
  year: 2020
  ident: 5714_CR4
  publication-title: Eur J Haematol
  doi: 10.1111/ejh.13343
  contributor:
    fullname: MQ Salas
– volume: 16
  start-page: 471
  issue: 3
  year: 1995
  ident: 5714_CR7
  publication-title: Bone Marrow Transpl
  contributor:
    fullname: DF Roychowdhury
– volume: 379
  start-page: 1846
  issue: 19
  year: 2018
  ident: 5714_CR6
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1807438
  contributor:
    fullname: CI Chapuy
– volume: 5
  start-page: 110
  issue: 1
  year: 2012
  ident: 5714_CR3
  publication-title: Case Rep Oncol
  doi: 10.1159/000337022
  contributor:
    fullname: SH Jung
– volume: 102
  start-page: 3865
  issue: 12
  year: 2003
  ident: 5714_CR8
  publication-title: Blood
  doi: 10.1182/blood-2003-05-1738
  contributor:
    fullname: Y Saunthararajah
– volume: 193
  start-page: 814
  issue: 4
  year: 2021
  ident: 5714_CR2
  publication-title: Br J Haematol
  doi: 10.1111/bjh.17463
  contributor:
    fullname: T Longval
SSID ssj0012842
Score 2.4345026
Snippet Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia,...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1775
SubjectTerms Anemia
Aniline Compounds
Azacitidine - therapeutic use
Bone marrow
Bone Marrow Diseases - complications
Bridged Bicyclo Compounds, Heterocyclic
Case Report
Case reports
Flow cytometry
Hematology
Hematopoietic Stem Cell Transplantation - adverse effects
Hemoglobin
Humans
Leukemia
Leukemia, Myeloid, Acute - complications
Leukemia, Myeloid, Acute - therapy
Medicine
Medicine & Public Health
Morphology
Oncology
Pathogenesis
Patients
Pyrazines
Red-Cell Aplasia, Pure - etiology
Stem cell transplantation
Steroids
Sulfonamides
Title Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report
URI https://link.springer.com/article/10.1007/s00277-024-05714-y
https://www.ncbi.nlm.nih.gov/pubmed/38556531
https://www.proquest.com/docview/3037663529/abstract/
https://www.proquest.com/docview/3029816559/abstract/
Volume 103
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaglRAXxLuBUg0SN7CU2HmsuW1RtxWoPbFSOUV-ShHbJGoTieUH8rsY29lUqHAglxwynjxm7PnsLzMm5F1eMoM4oKApV47mQhmqXF5Qxu3CMVsxXvnk5POL8mydf74sLm_zuMPP7jtGMgzUc65bGthGDCkUIUaW0-19su_Bg3flNVvO1AGOt4E6EFzQAo8pU-bvOv6MRncg5h16NESd1WPyaIKLsIz2fULu2fYpeXA-EeLPyK_TxtPdzdC0jQJ8E5zoWgN-dRX8MDZ0eiN_gGwNyJ9SoxzGKguIVMFnsfQ3KCz1OFi42tpN1xjY2PG7vWokKtOxdlPU1o_XFtsY8Ev9IPuQfglhi3Hw5D06om00hBqwXd81PjkSfJXo2GAIRdQ3MmY6tR8Bb4ABFCJn8ZysVydfP53RaWsGqhHvDbRKmWOVzZR0C5G6UmruZMWcQgThEAI7hBZOWlNyKVQlhMoqwxD5FGlucEaq-Auy13atPSBgNDPCOi50ZvJCCVU4xY314i41pUnI-52J6j5W4KjnWsvBoDUatA4GrbcJOdxZsZ56402NYbryyIqJhLydL2M_8h9AtrYbvQwTi6zECVZCXkbrz7fjiwJxL88S8mHnDrfK__0sr_5P_DV5yKJr0jQ7JHvD9WjfIOIZ1BHZX66Ojy_8-fTbl5Oj4PG_AXAHANg
link.rule.ids 315,786,790,27957,27958,41116,41558,42185,42627,52146,52269
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSMAF8SalwCBxA0uJnceaW4VaFuj21JV6i-zYlqJuk6ibSCw_kN_VsZ0EodIDuWY8TjK25xt_mTEhH9KcacQBGY25sjQVSlNl04wybhaWmYLxwiUnr07z5Tr9fp6dj0lh2-lv94mS9Cv1nOwWe7oRfQpFjJGkdHeX3HP11F3ItWaHM3eAC67nDgQXNMNrTJX5t46_3dENjHmDH_Vu5_gxeTTiRTgMBn5C7pjmKbm_GhnxZ-T319rx3XVfN7UCfBOMdI0Gt70Kbh3r22ojf4JsNMhfskI5dFYGEKqCS2Pptigsq6E3cLkzm7bWsDHDhbmsJSqrQvGmoK0brgy20eD2-kF2Pv8S_Bnj4Nh7HImmrsAXgW27tnbZkeDKRIcGva-ivpEh1an5DNgBelAIpMVzsj4-OvuypOPZDLRCwNfTImaWFSZR0i5EbHNZcSsLZhVCCIsY2CK2sNLonEuhCiFUUmiG0CeLU40hqeIvyF7TNuYVAV0xLYzlokp0mimhMqu4Nk7cxjrXEfk4majsQgmOci627A1aokFLb9ByF5GDyYrlOB23JfrpwkErJiLyfr6NE8l9ANmYdnAyTCySHCOsiLwM1p-744sMgS9PIvJpGg5_lN_-LPv_J_6OPFierU7Kk2-nP16ThywMUxonB2SvvxrMG4Q_vXrrR_s19hoBIw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtUwELWglSo2UN6BFozEDtwmdh7X7Kq2t4XSigWVyiryU4p6m0RtInH7gXwXYzsJj8ICkW3Gk4fHnuMcnwlCr9OcasABGYmZtCTlUhNp04xQZmaWmoKywomTj0_yw9P0w1l29pOK3-92HynJoGlwVZrqbrvVdnsSvsWeeoT8QgBvJClZ3karKQxbiPHVnYMvR_sTkwDTr2cSOOMkg2MQzvzZy6_J6QbivMGW-iQ0v4fEePth78n5Vt_JLXX9W2XH_3m-dXR3QKh4J4TUfXTL1A_Q2vHAwT9E3w4qx7BXXVVXEoNvWFsbjd0HXexmzq5RC_EVi1pjcS0U2EF6NBjAMXbCmfYKjIXqO4MvlmbRVBovTH9uLioBzlQoFxW8tf2lgTYaO3YBi9YrPrH_qzl2-wUg9k2lsC8727RN5fSY2BWmDg06X7d9IYK4qn6H4QKQs3GgSR6h0_n-591DMvwNgiiAmB0pYmppYRIp7IzHNheKWVFQKwG0WEDdFtCMFUbnTHBZcC6TQlMAW1mcalgES_YYrdRNbZ4irBXV3FjGVaLTTHKZWcm0ceY21rmO0JsxDMo2FP0op_LOvmtK6JrSd025jNDGGCnlMAFclYAMCgfmKI_Qq-k0DF33AkRtmt7ZUD5LcljTRehJiLDpcmyWAdRmSYTejtHyw_nf7-XZv5m_RGuf9ublx_cnR8_RHRrijcTJBlrpLnuzCXirky-GIfUdLPonNg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gilteritinib+combined+with+venetoclax+and+azacitidine+for+relapsed+acute+myeloid+leukemia+cocurrent+with+pure+red+cell+aplasia+after+allogeneic+hematopoietic+stem+cell+transplantation%3A+a+case+report&rft.jtitle=Annals+of+hematology&rft.au=Wang%2C+Jiawen&rft.au=Zhu%2C+Han&rft.au=Miao%2C+Kourong&rft.date=2024-05-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0939-5555&rft.eissn=1432-0584&rft.volume=103&rft.issue=5&rft.spage=1775&rft.epage=1777&rft_id=info:doi/10.1007%2Fs00277-024-05714-y&rft.externalDocID=10_1007_s00277_024_05714_y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-5555&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-5555&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-5555&client=summon